SCHEMBL24196355

SCHEMBL24196355

Cc1cc(-c2ccco2)ccc1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
CYP3A4 P08684 1/20 0.57
TSHR P16473 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
TAAR1 Q96RJ0 2/20 0.55
HDAC2 Q92769 1/20 0.48
LPL P06858 1/20 0.44
LIPG Q9Y5X9 1/20 0.44
PRMT6 Q96LA8 1/20 0.42
ERN1 O75460 1/20 0.42
PGR P06401 1/20 0.41
KEAP1 Q14145 1/20 0.41
CHEK1 O14757 2/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
FLT3 P36888 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3468657 0.85 TAAR1 (0.55) ALDH1A1TDP1TAAR1HDAC2LPL
SCHEMBL15519549 0.82 TAAR1 (0.61) ALDH1A1TDP1TAAR1HDAC2LPL
SCHEMBL3717306 0.82 TDP2 (0.51) ALDH1A1TAAR1LPLLIPGPRMT6
SCHEMBL11936142 0.81 PRMT6 (0.45) ALDH1A1CYP3A4TSHRTDP1TAAR1
SCHEMBL31201086 0.79 FLT3 (0.48) TAAR1LPLLIPGPRMT6ERN1
SCHEMBL20462888 0.78 ERN1 (0.46) TAAR1LPLLIPGPRMT6ERN1
SCHEMBL29208883 0.78 ERN1 (0.58) CYP3A4TDP1TAAR1PRMT6ERN1
SCHEMBL26673582 0.77 TAAR1 (0.54) TAAR1HDAC2LPLLIPGPRMT6
SCHEMBL19354601 0.76 TAAR1 (0.44) ALDH1A1TSHRTAAR1LPLLIPG
SCHEMBL13105784 0.75 PRMT6 (0.47) ALDH1A1TSHRTDP1TAAR1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022011211-A1 DEOXYNOJIRIMYCIN DERIVATIVES AS GLUCOSIDASE INHIBITORS EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) 2022-01-13 WO disclosed